Newborn screening in southeastern Europe

Urh Groselj1, Mojca Zerjav Tansek1, Andraz Smon1

  • 1University Children's Hospital Ljubljana, UMC Ljubljana, Ljubljana, Slovenia.

Insights

Newborn screening (NBS) for conditions like phenylketonuria and congenital hypothyroidism is lacking in many southeastern European countries. Expanding NBS programs in developing regions is a global health priority.

Area of Science:

  • Public Health
  • Pediatrics
  • Genetics

Background:

  • Newborn screening (NBS) is crucial for early detection of genetic and metabolic disorders.
  • Southeastern Europe serves as a model for developing regions regarding NBS implementation.
  • Assessing current NBS practices and future plans is vital for improving child health outcomes.

Purpose of the Study:

  • To evaluate the current status of NBS programs in southeastern Europe.
  • To identify challenges and future directions for NBS in the region.
  • To advocate for the prioritization of NBS in developing countries.

Main Methods:

  • A survey was conducted across 11 countries in southeastern Europe.
  • Data on implemented NBS tests and future plans were collected.
  • Analysis focused on the availability of phenylketonuria and congenital hypothyroidism screening.

Main Results:

  • Phenylketonuria screening was absent in 4 out of 11 countries.
  • Congenital hypothyroidism screening was absent in 3 out of 11 countries.
  • Extended NBS programs were not established in any surveyed country.

Conclusions:

  • Significant gaps exist in essential NBS programs within southeastern Europe.
  • Developing countries face substantial challenges in implementing comprehensive NBS.
  • Prioritizing NBS implementation globally is essential for preventing lifelong disabilities.

Related Concept Videos